Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism Nav1.1 blockers(Sodium channel protein type I alpha subunit blockers) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization CAMP4 Therapeutics Corp.Startup |
Active Organization CAMP4 Therapeutics Corp.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Epilepsies, Myoclonic | Preclinical | US | CAMP4 Therapeutics Corp.Startup | 03 Dec 2021 |